Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan olanzapine 5 mg
tablets to Eli Lilly's Zyprexa® 5 mg tablets following a single, oral 5 mg (1 x 5 mg) dose
administered under fed conditions.